Alpha 2.0
Login Register
» Authors » Melanie Smuk

Melanie Smuk

Explore the profile of Melanie Smuk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 43
Citations 453
Followers 0
Related Specialties
General Medicine
Public Health
Science
Top 10 Co-Authors
Andrew J Prendergast
Charlotte Clark
Stefan Priebe
Robert Ntozini
Joice Tome
Stephen A Stansfeld
Kamaldeep Bhui
Marian Mwapaura
Chloe Orkin
Clever Mazhanga
Published In
BMJ Open
Health Technol Assess
Trials
Wellcome Open Res
PLoS One
Affiliations
Soon will be listed here.
Recent Articles
1.
International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak
Apea V, Titanji B, Dakin F, Hayes R, Smuk M, Kawu H, et al.
PLOS Glob Public Health . 2025 Feb; 5(2):e0003704. PMID: 39951482
In May 2022, the most widespread outbreak of sustained transmission of mpox outside of countries historically affected countries in Western and Central Africa occurred. We aimed to examine the personal...
2.
School-age growth and development following infant feeding and/or water, sanitation, and hygiene interventions in rural Zimbabwe: long-term follow-up of a cluster-randomised trial
Piper J, Mazhanga C, Mwapaura M, Mapako G, Mapurisa I, Mashedze T, et al.
EClinicalMedicine . 2024 Dec; 78():102946. PMID: 39640932
Background: Few trials have explored long-term effects of interventions designed to reduce child stunting. We evaluated school-age outcomes in rural Zimbabwean children who received cluster-randomised water, sanitation and hygiene (WASH)...
3.
Effectiveness and cost-effectiveness of online recorded recovery narratives in improving quality of life for people with psychosis experience (NEON Trial): a pragmatic randomised controlled trial
Slade M, Rennick-Egglestone S, Robinson C, Newby C, Elliott R, Ali Y, et al.
Lancet Reg Health Eur . 2024 Nov; 47:101101. PMID: 39507771
Background: The Narrative Experiences Online (NEON) Intervention provides self-managed web-based access to mental health recovery narratives (n = 659). We evaluated effectiveness and cost-effectiveness in improving quality of life for...
4.
Growth, physical, and cognitive function in children who are born HIV-free: School-age follow-up of a cluster-randomised trial in rural Zimbabwe
Piper J, Mazhanga C, Mwapaura M, Mapako G, Mapurisa I, Mashedze T, et al.
PLoS Med . 2024 Oct; 21(10):e1004347. PMID: 39392862
Background: Globally, over 16 million children were exposed to HIV during pregnancy but remain HIV-free at birth and throughout childhood by 2022. Children born HIV-free (CBHF) have higher morbidity and...
5.
Development and validation of prediction models for fetal growth restriction and birthweight: an individual participant data meta-analysis
Allotey J, Archer L, Coomar D, Snell K, Smuk M, Oakey L, et al.
Health Technol Assess . 2024 Sep; 28(47):1-119. PMID: 39252507
Background: Fetal growth restriction is associated with perinatal morbidity and mortality. Early identification of women having at-risk fetuses can reduce perinatal adverse outcomes. Objectives: To assess the predictive performance of...
6.
Development and validation of a prognostic model to predict birth weight: individual participant data meta-analysis
Allotey J, Archer L, Snell K, Coomar D, Masse J, Sletner L, et al.
BMJ Med . 2024 Aug; 3(1):e000784. PMID: 39184566
Objective: To predict birth weight at various potential gestational ages of delivery based on data routinely available at the first antenatal visit. Design: Individual participant data meta-analysis. Data Sources: Individual...
7.
Piloting the adaptation of the Kaufman Assessment Battery for Children-2 edition (KABC-II) to assess school-age neurodevelopment in rural Zimbabwe
Piper J, Mazhanga C, Mapako G, Mapurisa I, Mashedze T, Munyama E, et al.
Wellcome Open Res . 2024 Jun; 7():274. PMID: 38910935
Background: Neurodevelopment assessment tools for low-resource settings are urgently needed. However, most available tools were developed in high-income settings and may lack cross-cultural validity. Methods: We piloted and adapted two...
8.
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics (SHARE LAI-net)
Ring K, Smuk M, Shongwe M, Okonta L, Mackie N, Ayres S, et al.
HIV Med . 2024 Jun; 25(10):1125-1134. PMID: 38858222
Introduction: Long-acting injectable cabotegravir + rilpivirine (CAB + RPV LAI) was approved for use in virally suppressed adults in the England and Wales national health service in November 2021. We...
9.
A cross-sectional investigation into the role of intersectionality as a moderator of the relation between youth adversity and adolescent depression/anxiety symptoms in the community
Havers L, Bhui K, Shuai R, Fonagy P, Fazel M, Morgan C, et al.
J Adolesc . 2024 May; 96(6):1304-1315. PMID: 38769710
Background: Adolescents exposed to adversity show higher levels of depression and anxiety, with the strongest links seen in socially/societally disadvantaged individuals (e.g., females, low socioeconomic status [SES]), as well as...
10.
Youth adversity and trajectories of depression/anxiety symptoms in adolescence in the context of intersectionality in the United Kingdom
Havers L, Shuai R, Fonagy P, Fazel M, Morgan C, Fancourt D, et al.
Psychol Med . 2024 Apr; 54(10):2677-2687. PMID: 38623689
Background: Youth adversity is associated with persistence of depression and anxiety symptoms. This association may be greater for disadvantaged societal groups (such as females) compared with advantaged groups (e.g. males)....